Mold Toxicity

Understanding the condition and the medical debate

Last reviewed: October 2026 · 55 sources

Educational only, not medical advice. This page shares general information and community experience. It isn’t a diagnosis or a treatment plan. Please talk with your doctor or another licensed healthcare provider before starting, stopping, or changing any test, supplement, medication, or treatment.

At a glance

  • “Mold toxicity” is not a formal diagnosis. It’s a term many patients and some clinicians use for illness they connect to mold and other contaminants in damp or water-damaged buildings. You may also hear “mold illness” or “toxic mold syndrome” [1, 2].
  • What’s well established: damp, moldy buildings are linked to stuffy nose, cough, wheeze, asthma flares and allergies, and to lung infections in people with weak immune systems or chronic lung disease [3, 4, 5].
  • What’s debated: whether mold and its toxins cause a long-lasting, whole-body illness with symptoms like fatigue and brain fog. Some clinicians treat it; major allergy organizations call it unproven [2, 6, 7].
  • The step everyone agrees on: find and fix the moisture problem and remove mold safely [3, 8].

If you feel worse in a certain building, or your health changed after a leak or flood, your symptoms are real and worth taking seriously. This page explains what is known, what is still argued about, and how to get a careful evaluation without being sold tests or treatments you don’t need.

What people mean by “mold toxicity”

Molds are fungi. There is always some mold around us, indoors and out, and it grows wherever there is moisture, such as around leaking roofs, windows and pipes or after a flood [3]. The most common indoor molds are Cladosporium, Penicillium and Aspergillus [3].

Molds can produce allergens (things that trigger allergic reactions), irritants and, in some cases, potentially toxic substances called mycotoxins [8]. Most of what is known about mycotoxins comes from food: the WHO describes them as natural toxins made by certain molds that grow on crops such as cereals, nuts, spices and dried fruit [9]. Much less is known about breathing them in at home. A 2023 German medical guideline notes that systematic studies of indoor inhalation exposure are not available [10].

Water-damaged buildings also contain more than mold. Researchers on different sides of the debate describe a mix of fungi, mycotoxins, bacteria, bacterial endotoxins and chemicals released by damp materials [4, 6, 11]. That mix is one reason this topic is hard to study.

“Mold toxicity” is often used loosely. Some people mean mold allergy; others mean a broader illness they believe is caused by toxins. Chronic Inflammatory Response Syndrome (CIRS) is a more specific framework for mold-related illness, developed by Dr. Ritchie Shoemaker. It has its own page: CIRS.

What major health organizations agree on

  • In 2004 the Institute of Medicine (now the National Academy of Medicine) found sufficient evidence linking indoor mold and damp spaces with upper respiratory symptoms, cough and wheeze in otherwise healthy people, asthma symptoms in people with asthma, and hypersensitivity pneumonitis (an immune lung condition) in people susceptible to it [3, 4].
  • The World Health Organization’s 2009 guidelines concluded that the most important effects of dampness and mould are more respiratory symptoms, allergies and asthma, plus disturbance of the immune system. The WHO’s main advice is to prevent persistent dampness and mold growth [5].
  • The CDC says damp and moldy environments “may cause a variety of health effects, or none at all.” People with asthma or mold allergy may have severe reactions, and people with weakened immune systems or chronic lung disease may get lung infections from mold [3].
  • The American Academy of Allergy, Asthma & Immunology (AAAAI) recognizes mold’s role in asthma, allergic rhinitis (hay fever), allergic bronchopulmonary aspergillosis, sinusitis and hypersensitivity pneumonitis [7].
  • A 2023 German medical guideline (AWMF) says mold exposure can irritate the mucous membranes and cause odor effects and “mood disorders,” and that the specific diseases linked to mold are allergies and mold infections [10].

Common symptoms

Symptoms with strong evidence behind them (mostly allergic, irritant or respiratory):

  • Stuffy or runny nose, sneezing, sore throat [1, 3]
  • Itchy, watery, red or burning eyes [1, 3]
  • Coughing or wheezing [3]
  • Asthma symptoms such as shortness of breath or chest tightness [1]
  • Skin rash or itchy skin [3, 8]

Broader symptoms many patients report. People in the mold-illness community, and clinicians who treat mold-related illness, also describe chronic fatigue, brain fog and memory problems, headaches, joint and muscle pain, light sensitivity, temperature swings and mood changes [6, 11, 12]. In one small study from Dr. Shoemaker’s practice, people from water-damaged buildings reported an average of 23 of 37 listed symptoms [11].

These broader symptoms are where the debate lies. The AAAAI says mold allergy “is not usually a cause of chronic symptoms such as headache and fatigue” [1], and critics point out that symptoms like these are common in many conditions [2]. That doesn’t mean your symptoms aren’t real. It means a careful evaluation should also look for other causes that are treatable.

Causes and risk factors

  • Moisture is the root cause. Mold grows on paper, cardboard, ceiling tiles, wood, drywall, carpet, insulation and dust once they stay damp [3]. The EPA puts it simply: “the key to mold control is moisture control” [8].
  • People at higher risk of problems include those with asthma or mold allergy, people with weakened immune systems and people with chronic lung disease [3]. The German guideline also lists people with severe influenza, severe COVID-19 or cystic fibrosis among groups needing special protection [10].
  • “Black mold.” Stachybotrys chartarum is a greenish-black mold that grows on materials like drywall and paper when they stay wet [13]. Despite its reputation, the CDC says no test proves a link between it and particular symptoms, and that all molds should be treated the same way when it comes to health risk and removal [13]. A detailed review found that studies linking it to serious illness mostly had significant methodological flaws [14].

How it’s evaluated

There is no single accepted test for “mold toxicity” [2, 10]. A good evaluation usually starts with your story: where you live and work, any leaks or musty smells, when symptoms started, and whether they ease when you’re away from a building.

Tests with wide acceptance:

  • Allergy testing. An allergist/immunologist can check whether mold is behind your symptoms; skin prick tests give results within minutes [1].
  • Asthma and lung evaluation if you have wheezing, breathlessness or chest tightness, since mold can trigger asthma [1, 3].

Tests that are commonly offered but disputed:

  • Urine mycotoxin tests. Critics say they have not been validated for diagnosing illness [2]. The German guideline states there is currently no medical reason to measure mycotoxins in blood or urine after indoor mold exposure [10].
  • Mold IgG antibody panels. Also described as unvalidated by critics [2].
  • CIRS lab panels (MSH, TGF-β1, C4a, MMP-9 and others) are used by Shoemaker-trained practitioners. See the CIRS page for what they measure and the debate around them [12].

Testing your home. The CDC does not recommend routine mold sampling: health effects differ from person to person, there are no set standards for an “acceptable” amount of mold, and visible mold should be removed whatever the type [3]. The EPA says sampling is usually unnecessary if you can see mold growing, and there are no federal limits for mold [15]. Dust tests such as ERMI and HERTSMI-2 are often recommended by CIRS practitioners [16, 17], but the EPA, which developed ERMI, calls it a research tool that “has not been validated for non-research purposes” and does not recommend routine public use [18, 19]. Our ERMI post explains what it can and can’t tell you.

Treatment approaches to discuss with your clinician

These are topics for a conversation with a licensed clinician, not instructions.

1. Reduce exposure. Fixing the water problem and cleaning up or removing moldy materials is the first step in every guideline we reviewed [3, 5, 8]. If you have health concerns, the EPA recommends talking to a health professional before starting cleanup, and it suggests professional help for areas larger than about 10 square feet, sewage or contaminated water, or a suspected contaminated heating and cooling system [8]. Our remediation decision tree can help you think through options.

2. Treat allergy and asthma. For mold allergy, the AAAAI lists avoiding exposure, over-the-counter or prescription antihistamines, eye drops, nasal sprays and allergy shots (immunotherapy) as options an allergist may discuss [1]. Asthma and fungal infections need their own medical care.

3. Approaches used by mold-illness clinicians. Some clinicians use binders (such as cholestyramine, charcoal or clay), glutathione and other antioxidants, antifungals, probiotics or sweating therapies; a 2013 review summarizes the rationale offered for these [6]. The Shoemaker Protocol for CIRS is the best-known and most-published of these approaches [20]. Evidence for them comes mostly from small studies by supportive clinicians, and major allergy organizations consider them unproven [2, 7]. Many experts caution against “detox” products and tests sold directly to patients [2]. For more detail, see What functional and integrative practitioners often recommend below.

If you try any of these, do it with a clinician who will watch for side effects and drug interactions. Some approaches carry real risks. For example, the Surviving Mold consensus statement itself tells patients to stop nasal, oral and IV antifungals, citing concern about drug-resistant bacteria [12].

Living with it: practical day-to-day help

  • Keep humidity down. The CDC suggests keeping indoor humidity no higher than 50%; the EPA says below 60%, ideally 30–50% [3, 8]. An inexpensive humidity meter helps you check [8].
  • Dry things fast. Dry water-damaged areas and items within 24–48 hours to prevent mold growth [3, 8].
  • Ventilate. Use bathroom and kitchen exhaust fans that vent outside, make sure your dryer vents outside, and fix leaks promptly [3].
  • Protect yourself during cleanup. The EPA suggests gloves, goggles and an N-95 respirator, and avoiding breathing in mold or spores [8]. If you are very sensitive, ask someone else to do the work.
  • Keep a simple log. Note symptoms, where you were, and any water events. Patterns over weeks are more useful to your clinician than a single bad day. Our CIRS starter checklist can help you organize questions.
  • Look after your mental health. Feeling dismissed is exhausting. A counselor who understands chronic illness can help, and if you are in crisis you can call or text 988 in the U.S. [21].

How mold relates to the other conditions

  • CIRS. CIRS is Dr. Shoemaker’s model of a chronic inflammatory illness triggered by biotoxins, most often from water-damaged buildings [12]. It is the framework many “mold toxicity” clinicians use.
  • MCAS. Many patients and some clinicians report mold as a trigger for mast cell symptoms. Research so far is mostly lab-based: certain molds can activate mast cells in the lab [22, 23, 24], while at least one fungal toxin has been shown to block mast cell activation [25].
  • POTS. A few small studies, mostly from one Finnish group, found more racing-heart and nervous-system symptoms in people from damp buildings [26, 27, 28]. Other scientists have criticized earlier work from this group [29], and mold is not on Dysautonomia International’s list of known causes of POTS [30]. An association has been reported; cause and effect has not been shown.
  • hEDS. hEDS is considered a heritable connective tissue disorder [31]. We did not find research suggesting mold causes it, though many people with hEDS also live with MCAS or POTS.

What’s known and what’s debated

Generally accepted:

  • Damp, moldy buildings are linked to respiratory symptoms, allergies and asthma [3, 4, 5].
  • Mold can cause infections in people with weakened immune systems or chronic lung disease [3].
  • Controlling moisture and removing mold is the main protective step [5, 8].

Still debated:

  • Whether mold or mycotoxins cause a chronic multi-system illness. Supportive clinicians describe one [6, 12]; the AAAAI calls such illnesses “largely or completely unproved” [7]; a 2019 review argues “toxic mold syndrome” has been disproven [2]; and the German guideline says there is no evidence linking indoor mold to conditions such as chronic fatigue syndrome or neurotoxic effects [10].
  • Whether urine mycotoxin tests, mold antibody panels and dust indexes like ERMI are useful for individual patients [2, 10, 18].
  • Whether binders and other “detox” treatments help [2, 6, 20].

Functional & integrative perspective · evidence varies

The functional and integrative perspective

How functional and integrative practitioners see mold illness

These are practitioners’ own models, described in their terms. The AAAAI [7], a 2019 review [2] and a 2023 German guideline [10] dispute that mold causes a broad chronic illness, so read each one as a hypothesis.

  • “Total load.” A 2013 review by an environmental-medicine physician describes water-damaged buildings as a mixed exposure and frames treatment around avoiding exposure and lowering “total load” and the “body burden” of toxins [6]. ISEAI says exposures “may be cumulative” and that why some people are affected more than others is still being investigated [38]. Evidence: a conceptual model; not tested as a whole.
  • Chemical sensitivity and “TILT.” Dr. Claudia Miller proposes “toxicant-induced loss of tolerance”: an exposure causes susceptible people to lose tolerance, and then tiny amounts of everyday chemicals trigger symptoms. She calls it a “yet-to-be-proven” theory [48]. Her research group has since proposed that fragrances and other chemicals sensitize mast cells [49]. Evidence: a theory. A review of provocation studies found that people with chemical sensitivity reacted mainly when they could tell real exposures from sham ones [50], and the German guideline found no evidence linking indoor mold to chemical sensitivity [10].
  • The “cell danger response.” Dr. Robert Naviaux proposes that cells shift their metabolism to protect themselves from chemical, physical or biological threats, and that chronic disease can follow when this response doesn’t switch off. He lists food and chemical sensitivity syndromes among his examples [51]. Evidence: a theoretical model; not tested in mold illness.
  • The CIRS model. Dr. Shoemaker’s CIRS model is the most detailed framework [12]. Evidence: small studies, mostly by its developers [20]. See the CIRS perspective.
  • Links to other conditions. ISEAI groups mold illness with MCAS and lists POTS among illnesses that may be “caused or exacerbated” by environmental toxins [38]. What the research shows for each link is in How mold relates; see also the MCAS and POTS perspectives. Evidence: associations and lab studies; cause and effect not shown.

What functional and integrative practitioners often recommend

Functional, integrative and environmental-medicine clinicians often use the approaches below, and many patients try them. Evidence varies, and most have not been tested in large controlled trials. The AAAAI says many proposed mold-related illnesses “remain largely or completely unproved” [7], a 2019 review argues “toxic mold syndrome” has been disproven [2], and a 2023 German guideline found no evidence linking indoor mold to conditions such as chronic fatigue syndrome [10]. This is not medical advice. Please talk with a licensed clinician before trying any of them.

  • Lowering exposure first. Shoemaker’s Protocol starts with leaving or fixing the water-damaged building [16], which matches mainstream advice to fix moisture and remove mold [8]. ISEAI’s indoor environmental professionals recommend an independent assessment before remediation and extra cleaning beyond the industry standard for sensitive patients [34]. ISEAI also suggests fragrance-free cleaning, low-VOC products and portable HEPA filters [35]. The EPA lists air fresheners and cleaning products among indoor sources of VOCs [36] and says removing sources and ventilating come first, with filtration as a supplement [37]. Evidence: general indoor-air guidance; not tested in controlled trials for mold illness. See our remediation decision tree.
  • The Shoemaker Protocol. For CIRS, the Protocol starts with removing exposure, then prescription binders (cholestyramine or colesevelam), treating MARCoNS (a nasal staph) and, last, a VIP nasal spray, with the VCS vision test used to track progress [16]. Evidence: small studies, mostly by its developers [11, 20]. Details are on our CIRS page.
  • Binders. Some clinicians add activated charcoal, clay or chlorella to prescription binders; a 2013 review by an environmental-medicine physician describes the reasoning [6]. Evidence: mostly lab, animal and food-toxin studies; we found no controlled trials of charcoal or clay in mold illness. Binders can also bind medicines and nutrients [6], so MedlinePlus advises spacing other medicines away from cholestyramine [39].
  • Glutathione and antioxidants. The same review describes glutathione (including nasal and nebulized forms) and other antioxidants as central for some clinicians, and notes that nebulized glutathione caused airway tightening in some people with asthma in one small study [6]. Evidence: lab and animal studies plus clinical experience; no controlled trials in mold illness found.
  • Sauna. Some clinicians use sauna to encourage sweating [6]. Evidence: no controlled trials in mold illness found. The NIH’s complementary-health center lists sauna among “detox” approaches and calls studies of these programs few and low quality [40]. POTS experts advise paying attention to temperature [41], heat is a listed mast cell trigger [42], and the review lists severe orthostatic hypotension as a reason not to use sauna [6].
  • Urine mycotoxin tests. A 2013 study found mycotoxins in the urine of 93% of 112 people with chronic fatigue syndrome, compared with controls the same lab had tested earlier; one author worked for the testing lab [43]. The CDC has warned that these tests aren’t FDA-approved, that levels predicting disease haven’t been established, and that mycotoxins from food show up in healthy people’s urine [44]. Evidence: not validated for diagnosis.
  • Nervous-system (“limbic”) retraining. Dr. Neil Nathan writes that he has recommended the Dynamic Neural Retraining System (DNRS) to 150–200 patients, including people with mold toxicity [45]. For the Gupta program, a small randomized trial in fibromyalgia and chronic fatigue (44 randomized, 21 finished) reported improvements [46]; a randomized trial in mold illness was registered in 2026 after it finished, and we found no published results [47]. Evidence: one small trial in related conditions; we found no controlled trials of DNRS.
  • Diet. Shoemaker’s Protocol uses gluten-free and low-amylose diets for specific lab results [16]; low-histamine diets are covered on our MCAS page. Evidence: clinical experience; we found no controlled diet trials in mold illness.

Want to know who’s behind this site? Read our story.

What to do next

General information, not a diagnosis or a treatment plan. A licensed clinician can tell you which of these steps fit you.

  1. Step 1Start this week

    • Make notes about your symptoms before your visit: when they started, how often they happen and whether they’re getting better or worse [52].
    • Note leaks, floods, musty smells and visible mold where you live and work, since the CDC links damp, moldy buildings to stuffy nose, cough, wheeze and asthma flares [3].
    • Our symptom checklist can help you organize what you notice.

  2. Step 2Choose who to see

    • Start with your primary care doctor: AHRQ calls your doctor “the first person to ask” [53].
    • An allergist/immunologist can check whether mold allergy is behind your symptoms [1]. If you have wheezing, breathlessness or chest tightness, ask about an asthma and lung evaluation [1, 3].
    • For occupational and environmental medicine, the AOEC directory lists clinics in the U.S. and Canada [54].
    • For patients looking for mold-illness clinicians, Surviving Mold lists physicians certified in the Shoemaker Protocol through Dr. Shoemaker’s own program [55], while major allergy organizations consider these approaches unproven [2, 7]. Evidence: proponent-run directory; contested approach.
    • See also the provider directories on our homepage.

  3. Step 3Tests to ask about

    • Allergy testing is widely accepted, and skin prick tests give results within minutes [1].
    • Urine mycotoxin tests are disputed: the CDC has warned about unvalidated urine mycotoxin tests [44], and Germany’s mold guideline sees no medical reason to measure mycotoxins in blood or urine after indoor mold exposure [10]. Evidence: contested tests.
    • At home, start with a moisture check rather than lab sampling: the CDC doesn’t recommend routine sampling [3], and the EPA says sampling is usually unnecessary if you can see mold [15].

  4. Step 4Everyday steps mainstream sources support

    • Fix the water problem and remove mold safely; this comes first in mainstream guidance [3, 5, 8].
    • Keep humidity low and dry wet areas and items quickly [3, 8].
    • If you have health concerns, the EPA advises talking with a health professional before cleanup and getting professional help for large areas [8].

  5. Step 5Prepare for the appointment

    • Bring a list of all the medicines you take [53]. Our Doctor visit prep sheet has space for your exposure history and past results.
    • If you feel dismissed, consider a second opinion: AHRQ says wanting one “is not pushy or rude” and suggests asking for a doctor who doesn’t work in the same office [53].
    • For home guidance, the EPA’s mold and moisture guide [8] and the CDC’s mold pages [3] are reliable starting points.
    • Then use the Questions to ask your doctor below.

  6. Step 6When to get urgent care

    • Call 911 for severe shortness of breath at rest, bluish lips or face, or severe chest pain [32], or signs of anaphylaxis such as trouble breathing or throat swelling [33]. If you’re having thoughts of suicide, call or text 988 [21].
    • See the full list under When to get urgent help.

Questions to ask your doctor

  • Could my symptoms be allergy or asthma? Should I see an allergist?
  • What else should we rule out, given my symptoms?
  • If you recommend a mold-related test, how reliable is it, what would the result change, and what does it cost?
  • Is it safe for me to be involved in cleanup, or should someone else do it?
  • If I try a treatment for mold-related illness, how will we judge whether it’s working, and what side effects should I watch for?
  • Would it help to see a specialist (allergist, pulmonologist, or a clinician experienced in environmental illness)?

When to get urgent help

Call 911 or your local emergency number if you have severe shortness of breath at rest, bluish lips or face, severe chest pain, or drowsiness or confusion with breathing trouble [32]. Signs of a severe allergic reaction (anaphylaxis), such as trouble breathing, throat or face swelling, or fainting, also need emergency care; use epinephrine if your clinician has prescribed it [33]. If you are having thoughts of suicide, call or text 988 [21].

Sources

Numbers in brackets in the text link to these sources. Links were checked in October 2026. Some sources are written by people who support a particular approach; we've tried to say so in the text.

  1. American Academy of Allergy, Asthma & Immunology (AAAAI). Mold Allergy (patient page; updated July 8, 2026). https://www.aaaai.org/conditions-treatments/allergies/mold-allergy
  2. Chang C, Gershwin ME. The Myth of Mycotoxins and Mold Injury. Clin Rev Allergy Immunol. 2019;57(3):449-455. PMID: 31608429. https://doi.org/10.1007/s12016-019-08767-4
  3. Centers for Disease Control and Prevention (CDC), National Center for Environmental Health. Mold (About mold). Reviewed Sept 26, 2024. https://www.cdc.gov/mold-health/about/index.html
  4. Institute of Medicine (US) Committee on Damp Indoor Spaces and Health. Damp Indoor Spaces and Health. National Academies Press; 2004. PMID: 25009878. https://www.ncbi.nlm.nih.gov/books/NBK215643/
  5. World Health Organization (WHO) Regional Office for Europe. WHO Guidelines for Indoor Air Quality: Dampness and Mould. 2009. PMID: 23785740. https://www.ncbi.nlm.nih.gov/books/NBK143941/
  6. Hope J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal. 2013;2013:767482. PMID: 23710148. https://pmc.ncbi.nlm.nih.gov/articles/PMC3654247/
  7. Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA. The medical effects of mold exposure (AAAAI position paper). J Allergy Clin Immunol. 2006;117(2):326-333. PMID: 16514772. https://doi.org/10.1016/j.jaci.2005.12.001
  8. U.S. Environmental Protection Agency (EPA). A Brief Guide to Mold, Moisture and Your Home. Web page, accessed October 10, 2026. https://www.epa.gov/mold/brief-guide-mold-moisture-and-your-home
  9. World Health Organization. Mycotoxins (fact sheet). Web page, accessed October 10, 2026. https://www.who.int/news-room/fact-sheets/detail/mycotoxins
  10. HurraĂź J, Heinzow B, Walser-Reichenbach S, et al. AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023. Allergol Select. 2024;8:90-198. PMID: 38756207. https://pmc.ncbi.nlm.nih.gov/articles/PMC11097193/
  11. Shoemaker RC, House DE. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol Teratol. 2006;28(5):573-588. PMID: 17010568. https://doi.org/10.1016/j.ntt.2006.07.003
  12. Shoemaker R, Johnson K, Jim L, et al. Diagnostic Process for Chronic Inflammatory Response Syndrome (CIRS): A Consensus Statement. Report of the Consensus Committee of Surviving Mold. Internal Medicine Review. 2018;4(5). https://www.survivingmold.com/Publications/CIRS_diagnostic_protocol_final_5_1_2018.pdf
  13. CDC, National Center for Environmental Health. Stachybotrys chartarum Facts. May 29, 2024. https://www.cdc.gov/mold-health/data-research/facts-stats/index.html
  14. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev. 2003;16(1):144-172. PMID: 12525430. https://pmc.ncbi.nlm.nih.gov/articles/PMC145304/
  15. U.S. EPA. Mold Testing or Sampling. Web page, accessed October 10, 2026. https://www.epa.gov/mold/mold-testing-or-sampling
  16. Ou D. Steps of the Shoemaker Protocol (2014; hosted by Surviving Mold). https://www.survivingmold.com/STEPS_OF_THE_SHOEMAKER_PROTOCOL_3.PDF
  17. Surviving Mold (Shoemaker RC). HERTSMI-2 Scoring System (web page). Web page, accessed October 10, 2026. https://www.survivingmold.com/resources-for-patients/diagnosis/hertsmi-2
  18. U.S. EPA. Environmental Relative Moldiness Index (ERMI) (web page). Web page, accessed October 10, 2026. https://www.epa.gov/air-research/environmental-relative-moldiness-index-ermi
  19. U.S. EPA. The Environmental Relative Moldiness Index (ERMI) fact sheet. September 2021. https://www.epa.gov/system/files/documents/2021-09/updated-fact-sheet.ermi-_9.9.21.final_new-template_508-compliant_0.pdf
  20. Dooley M, Vukelic A, Jim L. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment. Ann Med Surg (Lond). 2024;86(12):7248-7254. PMID: 39649915. https://pmc.ncbi.nlm.nih.gov/articles/PMC11623837/
  21. National Institute of Mental Health (NIMH). Help for Mental Illnesses. Web page, accessed October 10, 2026. https://www.nimh.nih.gov/health/find-help
  22. Kritas SK, Gallenga CE, D'Ovidio C, et al. Impact of mold on mast cell-cytokine immune response. J Biol Regul Homeost Agents. 2018;32(4):763-768. PMID: 30043558. https://europepmc.org/article/MED/30043558
  23. Urb M, Pouliot P, Gravelat FN, Olivier M, Sheppard DC. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis. 2009;200(3):464-472. PMID: 19527167. https://doi.org/10.1086/600070
  24. Ratnaseelan AM, Tsilioni I, Theoharides TC. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clin Ther. 2018;40(6):903-917. PMID: 29880330. https://doi.org/10.1016/j.clinthera.2018.05.004
  25. Niide O, Suzuki Y, Yoshimaru T, et al. Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism. Clin Immunol. 2006;118:108-116. PMID: 16213796. https://doi.org/10.1016/j.clim.2005.08.012
  26. Hyvönen S, Lohi J, Tuuminen T. Moist and mold exposure is associated with high prevalence of neurological symptoms and MCS in a Finnish hospital workers cohort. Saf Health Work. 2020;11(2):173-177. PMID: 32596012. https://pmc.ncbi.nlm.nih.gov/articles/PMC7303478/
  27. Hyvönen S, Poussa T, Lohi J, Tuuminen T. High prevalence of neurological sequelae and multiple chemical sensitivity among occupants of a Finnish police station damaged by dampness microbiota. Arch Environ Occup Health. 2021;76(3):145-151. PMID: 32544007. https://doi.org/10.1080/19338244.2020.1781034
  28. Tuuminen T. The roles of autoimmunity and biotoxicosis in sick building syndrome as a "starting point" for irreversible dampness and mold hypersensitivity syndrome. Antibodies (Basel). 2020;9(2):26. PMID: 32580407. https://pmc.ncbi.nlm.nih.gov/articles/PMC7345570/
  29. Heinzow HS, Heinzow BGJ. Commentary: Severe sequelae to mold-related illness as demonstrated in two Finnish cohorts. Front Immunol. 2017;8:1694. PMID: 29270170. https://pmc.ncbi.nlm.nih.gov/articles/PMC5725433/
  30. Dysautonomia International. Postural Orthostatic Tachycardia Syndrome. Web page, accessed October 10, 2026. https://www.dysautonomiainternational.org/page.php?ID=30
  31. The Ehlers-Danlos Society. Hypermobile Ehlers-Danlos Syndrome (hEDS). Web page, accessed October 10, 2026. https://www.ehlers-danlos.com/heds/
  32. MedlinePlus. Asthma. Web page, accessed October 10, 2026. https://medlineplus.gov/ency/article/000141.htm
  33. MedlinePlus (U.S. National Library of Medicine). Anaphylaxis. Web page, accessed October 10, 2026. https://medlineplus.gov/ency/article/000844.htm
  34. ISEAI Indoor Environmental Professional (IEP) Committee. Finding the Right Professionals to Remediate Your Home. May 1, 2024. Web page, accessed October 11, 2026. https://iseai.org/finding-the-right-professionals-to-remediate-your-home/
  35. ISEAI. Clean Indoor Air on a Budget – Helpful Tips for Chronically Ill Patients. June 29, 2023. Web page, accessed October 11, 2026. https://iseai.org/clean-indoor-air-on-a-budget/
  36. U.S. Environmental Protection Agency (EPA). Volatile Organic Compounds’ Impact on Indoor Air Quality. Web page, accessed October 11, 2026. https://www.epa.gov/indoor-air-quality-iaq/volatile-organic-compounds-impact-indoor-air-quality
  37. U.S. Environmental Protection Agency (EPA). Air Cleaners and Air Filters in the Home. Web page, accessed October 11, 2026. https://www.epa.gov/indoor-air-quality-iaq/air-cleaners-and-air-filters-home
  38. International Society for Environmentally Acquired Illness (ISEAI). About EAI – Environmentally Acquired Illness. Web page, accessed October 11, 2026. https://iseai.org/about-eai/
  39. MedlinePlus (U.S. National Library of Medicine). Cholestyramine Resin (drug information). Web page, accessed October 11, 2026. https://medlineplus.gov/druginfo/meds/a682672.html
  40. National Center for Complementary and Integrative Health (NCCIH). “Detoxes” and “Cleanses”: What You Need To Know. Last updated March 2025. Web page, accessed October 11, 2026. https://www.nccih.nih.gov/health/detoxes-and-cleanses-what-you-need-to-know
  41. Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828. PMID: 34144933. https://pmc.ncbi.nlm.nih.gov/articles/PMC8455420/
  42. The Mast Cell Disease Society (TMS). Symptoms and Triggers of Mast Cell Activation. Web page, accessed October 11, 2026. https://tmsforacure.org/signs-symptoms-triggers/symptoms-and-triggers-of-mast-cell-activation/
  43. Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins (Basel). 2013;5(4):605-617. PMID: 23580077. https://pmc.ncbi.nlm.nih.gov/articles/PMC3705282/
  44. Kawamoto M, Page E. Notes from the field: Use of unvalidated urine mycotoxin tests for the clinical diagnosis of illness — United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(6):157-158. PMID: 25695323. https://pmc.ncbi.nlm.nih.gov/articles/PMC4584707/
  45. Nathan N. Newsletter #14: Dysfunctional Limbic System. August 29, 2018. Web page, accessed October 11, 2026. https://neilnathanmd.com/newsletter-14-dysfunctional-limbic-system/
  46. Toussaint LL, Whipple MO, Abboud LL, Vincent A, Wahner-Roedler DL. A mind-body technique for symptoms related to fibromyalgia and chronic fatigue. Explore (NY). 2012;8(2):92-98. PMID: 22385563. https://doi.org/10.1016/j.explore.2011.12.003
  47. ClinicalTrials.gov. Amygdala Insula Retraining (AIR) in the Management of Mold Illness Symptoms (NCT07425431). First posted February 20, 2026. Web page, accessed October 11, 2026. https://clinicaltrials.gov/study/NCT07425431
  48. Miller CS. Toxicant-induced loss of tolerance—an emerging theory of disease? Environ Health Perspect. 1997;105(Suppl 2):445-453. PMID: 9167978. https://pmc.ncbi.nlm.nih.gov/articles/PMC1469811/
  49. RincĂłn R, Perales R, Palmer RF, et al. Environmental house calls can reduce symptoms of chemical intolerance: a demonstration of personalized exposure medicine. Prim Health Care Res Dev. 2024;25:e53. PMID: 39434594. https://pmc.ncbi.nlm.nih.gov/articles/PMC11569860/
  50. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. J Allergy Clin Immunol. 2006;118(6):1257-1264. PMID: 17137865. https://doi.org/10.1016/j.jaci.2006.07.046
  51. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7-17. PMID: 23981537. https://doi.org/10.1016/j.mito.2013.08.006
  52. National Institute on Aging (NIA). What Do I Need to Tell the Doctor? Accessed October 17, 2026. https://www.nia.nih.gov/health/medical-care-and-appointments/what-do-i-need-tell-doctor
  53. Agency for Healthcare Research and Quality (AHRQ). Next Steps After Your Diagnosis: Finding Information and Support (patient booklet, PDF). Accessed October 17, 2026. https://www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/diagnosis-treatment/diagnosis/diaginfo/diaginfo.pdf
  54. Association of Occupational and Environmental Clinics (AOEC). Connect with Occupational and Environmental Medicine Clinicians through the AOEC Clinic Directory. Web page, accessed October 17, 2026. https://aoec.org/connect/
  55. Surviving Mold (Shoemaker RC). Find Shoemaker Certified Practitioners (In My Area). Web page, accessed October 17, 2026. https://www.survivingmold.com/shoemaker-protocol/find-a-physician-in-my-area

Related free guides

Helpful resources

Change The Air Foundation

Mold education and safe-home resources.

More on the homepage